🔴 Neurosense Therapeutics is trading 5.5% down today as XBI falls more than 2%

Neurosense Therapeutics is trading 5.5% down at $3.61, with biotech and broader-market weakness the strongest available explanation.

• The XBI is down more than 2%, while the Nasdaq is down more than 1%.
• No clear company-specific catalyst for October 8 is confirmed; the first-half financial-results business update was published September 25, not October 8.
• A rate-pressured backdrop has also weighed on biotech risk appetite.